2 assets in Substance Withdrawal Syndrome

Therapeutic assets addressing Substance Withdrawal Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Probenecid Substance Withdrawal Syndrome	University of Calgary	P2	CCC (53)
Buprenorphine Substance Withdrawal Syndrome	Medical University of South Carolina	P1/2	CCC (48)